4//SEC Filing
Segal Lloyd Mitchell 4
Accession 0001415889-25-007239
CIK 0001808158other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:00 PM ET
Size
8.6 KB
Accession
0001415889-25-007239
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Shares
2025-03-04+40,000→ 145,573 total - Award
Employee Stock Option (right to buy)
2025-03-04+237,000→ 237,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (237,000 underlying)
Holdings
- 107,558(indirect: See footnote)
Common Shares
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 895 and 2,000 shares acquired on August 15, 2024 and February 15, 2025, respectively, under the Issuer's employee stock purchase plan.
- [F3]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001477123
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:00 PM ET
- Size
- 8.6 KB